Alongside NLRP3 activation, circulating cell-free mitochondrial DNA (ccf-mtDNA) release was also significantly reduced by similar levels following MCC950 and BFE treatment, indicating that both interventions mitigated mitochondrial stress in BD and CT COs (Fig. 8D). Here, NLRP3 is linked to Behcet disease.